A Clinical Index to Predict Progression from Mild Cognitive Impairment to Dementia Due to Alzheimer's Disease
Authors:
Open Access
- 8 December 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (12) , e113535
Abstract
Mild cognitive impairment is often a precursor to dementia due to Alzheimer's disease, but many patients with mild cognitive impairment never develop dementia. New diagnostic criteria may lead to more patients receiving a diagnosis of mild cognitive impairment. To develop a prediction index for the 3-year risk of progression from mild cognitive impairment to dementia relying only on information that can be readily obtained in most clinical settings. 382 participants diagnosed with amnestic mild cognitive impairment enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI), a multi-site, longitudinal, observational study. Demographics, comorbid conditions, caregiver report of participant symptoms and function, and participant performance on individual items from basic neuropsychological scales. Progression to probable Alzheimer's disease. Subjects had a mean (SD) age of 75 (7) years and 43% progressed to probable Alzheimer's disease within 3 years. Important independent predictors of progression included being female, resisting help, becoming upset when separated from caregiver, difficulty shopping alone, forgetting appointments, number of words recalled from a 10-word list, orientation and difficulty drawing a clock. The final point score could range from 0 to 16 (mean [SD]: 4.2 [2.9]). The optimism-corrected Harrell's c-statistic was 0.71(95% CI: 0.68–0.75). Fourteen percent of subjects with low risk scores (0–2 points, n = 124) converted to probable Alzheimer's disease over 3 years, compared to 51% of those with moderate risk scores (3–8 points, n = 223) and 91% of those with high risk scores (9–16 points, n = 35). An index using factors that can be obtained in most clinical settings can predict progression from amnestic mild cognitive impairment to probable Alzheimer's disease and may help clinicians differentiate between mild cognitive impairment patients at low vs. high risk of progression.Keywords
This publication has 39 references indexed in Scilit:
- Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementiaNeurobiology of Aging, 2011
- Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classificationNeurobiology of Aging, 2011
- “Knowing is Better”: Preferences of Diverse Older Adults for Discussing PrognosisJournal of General Internal Medicine, 2011
- Outcomes of Mild Cognitive Impairment by DefinitionArchives of Neurology, 2011
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeThe Lancet Neurology, 2010
- Mild Cognitive ImpairmentArchives of Neurology, 2009
- Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD indexBrain, 2009
- Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI☆NeuroImage, 2009
- Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imagingNeurobiology of Aging, 2008
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008